BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$0.89
Tradestie Score
49
Market Cap
$50.49M
Revenue Growth
0.2%
Analyst Upside
+1477.6%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
COLL Collegium Pharmaceutical, Inc. Common Stock
$36.08
$1.11B 17.6 56 Compare
CRON Cronos Group Inc. Common Share
$2.79
$1.02B - 60 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 55 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$42.32
$543.32M - 59 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$1.79
$275.13M - 49 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.86
$237.15M 6.5 51 Compare
BIOA BioAge Labs, Inc. Common Stock
$22.81
$212.23M - 59 Compare
ATRA Atara Biotherapeutics, Inc
$8.39
$101.48M - 50 Compare
KPTI Karyopharm Therapeutics Inc.
$9.51
$53.85M - 48 Compare
KYNB KYNB
$7.23
- - 53 Compare

Data updated: Jul 18, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry